Winner
Johnson & Johnson (J&J) UK Communications & Public Affairs (CPA) Team
Summary of work
Executive Summary
In 2025, the Johnson & Johnson (J&J) UK Communications & Public Affairs (CPA) team were essential strategic partners as the organisation worked through a year marked by heightened scrutiny of healthcare access, NHS pressures and industry trust, ensuring patient outcomes remained central to portfolio, corporate reputation, policy, media, digital and employee communications and public affairs.
Working as a small, highly integrated team, CPA shifted from reactive response to proactive agenda setting. We embedded patient insight into planning, humanised complex access milestones through credible patient and clinician voices and partnered with patient organisations to drive action.
Bolstered by an ambitious goal to be the number one UK oncology company by 2030, the integrated cross‑functional team strengthened oncology leadership through national media engagement and improved share of voice, delivered durable policy progress for earlier diagnosis in blood cancer, provided clear communication of key HTA and regulatory milestones, and demonstrated that responsible disease awareness can change behaviour through a national prostate cancer campaign.
The team increased impact through disciplined operating rhythms, message consistency and evidence‑led evaluation. The result was a stronger, more visible and more trusted organisation, and a CPA function recognised internally as an essential strategic partner when shaping decisions and outcomes.
Judges’ comments
J&J’s CPA team were a highlight integrated, disciplined and credible in-house function, delivering sustained impact. Their teamwork was evident, they presented well with great results. They had a focused strategy and clear achievements versus objectives. They are clearly at the top of their game.
